Gene · 6955
Papers2,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma. | Curr Issues Mol Biol | 2023 | 37998738 | PubTator, text mining | PubMed |
Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy. | ESMO Open | 2023 | 37995426 | PubTator, text mining | PubMed |
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| A spatial human thymus cell atlas mapped to a continuous tissue axis. | bioRxiv | 2023 | 37986877 | PubTator, text mining | PubMed |
| High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq. | Nat Commun | 2023 | 37973846 | PubTator, text mining | PubMed |
| Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis. | Cell Commun Signal | 2023 | 37957625 | PubTator, text mining | PubMed |
| Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. | Nat Commun | 2023 | 37923752 | PubTator, text mining | PubMed |
| Landscape of enhancer disruption and functional screen in melanoma cells. | Genome Biol | 2023 | 37904237 | PubTator, text mining | PubMed |
| Sex- and age-specific aspects of human peripheral T-cell dynamics. | Front Immunol | 2023 | 37901211 | PubTator, text mining | PubMed |
| Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease. | Medicina (Kaunas) | 2023 | 37893507 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| Self-reactive germline-like TCR alpha chains shared between blood and pancreas. | Res Sq | 2023 | 37886513 | PubTator, text mining | PubMed |
| Nano transdermal system combining mitochondria-targeting cerium oxide nanoparticles with all-trans retinoic acid for psoriasis. | Asian J Pharm Sci | 2023 | 37881797 | PubTator, text mining | PubMed |
| Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma. | Commun Med (Lond) | 2023 | 37880538 | PubTator, text mining | PubMed |
| Maternal thyroid hormone receptor β activation in mice sparks brown fat thermogenesis in the offspring. | Nat Commun | 2023 | 37875497 | PubTator, text mining | PubMed |
| Human thymic putative CD8αα precursors exhibit a biased TCR repertoire in single cell AIRR-seq. | Sci Rep | 2023 | 37853083 | PubTator, text mining | PubMed |
| Association Between Thyroid Parameters and Subclinical Atherosclerosis in Hospitalised Euthyroid Patients with Type 2 Diabetes Mellitus. | Diabetes Metab Syndr Obes | 2023 | 37849978 | PubTator, text mining | PubMed |
| Gallstone Disease and Its Correlation With Thyroid Disorders: A Narrative Review. | Cureus | 2023 | 37842424 | PubTator, text mining | PubMed |
| Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia. | Cancer Drug Resist | 2023 | 37842238 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Donor-Reactive T Cells Reveals Role of Apoptosis in Donor-Specific Hyporesponsiveness of Kidney Transplant Recipients. | Int J Mol Sci | 2023 | 37833911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6955/papers?page=10